Hepatotoxicity Signals Across Azole Antifungals: Is Isavuconazole Safer? A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 31; Pres time: Oct 22, 2026; 12:15 PM - 01:30 PM; Location: Virtual Presentation; No abstract available
Adverse events • Infectious Disease
|
|
Varshini Thiruvadi, MD; Rakshana Ravichandran, MD; Yusuf Kagzi, MD; Salman Ahsan, MD; Mohammad Alqaisieh, MD; Manasa Kandula, MD (she/her/hers); Denise Francisco, MD (she/her/hers)
|